Investment Focus - Alphabet (GOOGL US) is expected to maintain good visibility in its advertising business due to the gradual release of its valuation under pressure from AI search, with a projected 30%+ growth in cloud business for the year and margin improvement driven by scale effects [1] - Alibaba (BABA US) is anticipated to see a cloud business growth rate of 28%-30%, benefiting from strong momentum in instant retail, with Taobao expected to achieve a 20-30% MAU growth driven by flash purchase [1] - NVIDIA (NVDA US) is projected to achieve strong revenue growth in FY2027, with GB300 series products expected to account for two-thirds of Blackwell series products, and a revenue target of $500 billion over the next five quarters [1] - Tencent (700 HK) is recommended as a top pick, with a target price of 700, driven by steady growth in core gaming and advertising businesses, and a projected near 20% growth rate in advertising [3] - New Oxygen (SY US) is focusing on the light medical beauty sector with a rapid expansion plan, aiming to open 50 self-operated stores by 2025, supported by a strong marketing capability and low customer acquisition costs [3] - Ctrip (TCOM US) is expected to benefit from steady growth in domestic leisure travel and the recovery of outbound travel, with a projected revenue growth of 14% to 71.1 billion yuan in 2026 [3] - Huazhu (HTHT US) is transitioning to a high-margin franchise model, with a target price of $52, supported by a strong recovery in industry RevPar [4] - Futu (FUTU US) is positioned for long-term growth in the virtual asset business, with a user base of 3.1 million and a current valuation offering a safety margin [4] - AIA (1299 HK) is expected to see steady growth in new business value and operational indicators, with a forward PEV of 1.46x [4] - Dongfang Electric (1072 HK) is actively involved in global power station project contracting, with significant opportunities in the U.S. market due to the demand for power supply capabilities [9]

Investment Rating - The report maintains an "Outperform" rating for the company, with a target price of RMB 47.84 [4][10][16]. Core Insights - The spin-off of Mandy International aligns with the interests of both 3SBio and Mandy International shareholders, allowing 3SBio to focus on innovative drug development while Mandy specializes in consumer healthcare products [1][4]. - The company is expected to see significant revenue growth, with forecasts of RMB 19.18 billion, RMB 11.90 billion, and RMB 14.05 billion for 2025-2027, respectively [8][16]. - Mandy International has established a leading position in the hair health sector, with flagship Minoxidil products holding approximately 57% and 71% market shares in the hair loss and Minoxidil markets in China for 2024 [4][16]. Financial Summary - Revenue projections for 2023A to 2027E are as follows: RMB 7.816 billion (2023A), RMB 9.108 billion (2024A), RMB 19.178 billion (2025E), RMB 11.895 billion (2026E), and RMB 14.051 billion (2027E), reflecting a CAGR of 21.7% from 2022 to 2024 [3][4][16]. - Net profit attributable to shareholders is forecasted to be RMB 1.549 billion (2023A), RMB 2.090 billion (2024A), RMB 10.214 billion (2025E), RMB 2.813 billion (2026E), and RMB 3.515 billion (2027E) [3][4][16]. - The company’s PE ratio is projected to be 11.75 (2023A), 7.07 (2024A), 7.25 (2025E), 26.33 (2026E), and 21.06 (2027E) [3][4]. Business Development - The spin-off is expected to enhance Mandy International's image among clients and partners, improving its position for business negotiations and attracting more opportunities [4][16]. - Mandy International is focused on developing blockbuster consumer medical products, with a strong emphasis on skin health and weight management solutions [4][16]. - The company has shown stable growth in past performance, with revenue figures of RMB 982 million, RMB 1.23 billion, and RMB 1.46 billion from 2022 to 2024, alongside high gross profit margins [4][16].

Investment Rating - The report maintains an "Outperform" rating for the company [1][4]. Core Insights - The company's revenue showed stable growth in the first half of FY25, with a year-on-year increase of 2.1%, while sales experienced nearly double-digit growth. However, profit margins were temporarily pressured due to rising raw material costs and increased expenses from organizational optimization [10][11]. - The forecasted EPS for FY25-27 is RMB 0.34, 0.38, and 0.41 respectively, with a target price set at RMB 6.12 per share, equivalent to HKD 6.73 at an exchange rate of 0.91 [4][9]. Financial Summary - Total revenue for FY23A was RMB 23,924.37 million, with a slight decrease of 0.3% expected in FY24A. Revenue is projected to grow by 1.7% in FY25E, 3.7% in FY26E, and 2.7% in FY27E [3]. - Gross profit for FY23A was RMB 10,990.92 million, with a forecasted gross profit margin decrease of 1.1 percentage points due to rising costs of imported whole milk powder and palm oil [10]. - Net profit attributable to shareholders for FY23A was RMB 3,990.47 million, with a projected decrease of 7.1% in FY25E, followed by growth of 12.1% in FY26E and 8.1% in FY27E [3][4]. Product Performance - Dairy beverage revenue declined by 1.1% year-on-year, primarily due to a slight drop in Wangzai Milk sales, while other beverage categories grew nearly 40%. The gross profit margin for dairy beverages decreased by 2.5 percentage points [11]. - Rice crackers saw a revenue increase of 3.5% year-on-year, with a gross profit margin increase of 1.3 percentage points, driven by strong growth in emerging channels [11]. - Snack food revenue increased by 7.7% year-on-year, with ice cream and candy categories showing positive growth trends [12]. Market Channels - Snack wholesale and emerging channels performed exceptionally well, with snack wholesale revenue growing significantly and accounting for about 15% of total group revenue. Emerging channels also saw double-digit growth, contributing over 10% to total revenue [12]. - The overseas market continued to show positive trends, with revenue growth in regions such as Japan, India, and Africa [12].

Investment Rating - The report assigns an "Outperform" rating to several companies in the new energy sector, including 阳光电源 (Sunlight Power), 天合光能 (Trina Solar), TCL 中环 (TCL Zhonghuan), 大金重工 (Daikin Heavy Industries), and others, with target prices ranging from 8.54 to 129.78 [1]. Core Insights - Solid-state batteries are emerging as a solution to the dual challenges of energy density and safety, with energy density potentially reaching 500 Wh/kg, significantly higher than traditional lithium-ion batteries [4][21]. - The global market for solid-state batteries is expected to grow rapidly, with shipments projected to reach 36 GWh in 2025 and over 600 GWh by 2030, indicating a significant increase in market penetration from approximately 0.2% in 2024 to an expected 10% by 2030 [38][39]. - China is positioned as a leader in the solid-state battery industry, supported by a comprehensive policy framework and significant market demand, with major companies like 宁德时代 (CATL) and 比亚迪 (BYD) making substantial advancements in production timelines [5][39][50]. Summary by Sections 1. Solid-State Battery Development - Traditional lithium-ion batteries face limitations in energy density and safety, with energy density nearing theoretical limits and safety concerns due to flammable electrolytes [13][19]. - Solid-state batteries utilize solid electrolytes, eliminating flammability risks and enhancing energy density, thus addressing key industry concerns [22][25]. 2. Global Policy Landscape - The development of solid-state batteries has become a strategic priority for major economies, with diverse approaches: Japan focuses on technological leadership, China on rapid commercialization, South Korea on industry integration, and the U.S. on capital-driven innovation [32][33]. - Various countries are implementing supportive policies to foster the growth of the solid-state battery sector, with significant investments in research and development [68]. 3. China’s Market Position - China dominates the global lithium battery market, accounting for 59% of the total installed capacity in 2024, with a strong focus on solid-state battery technology as a key growth area [39][42]. - The Chinese government has elevated solid-state battery research to a strategic level, aiming to secure technological leadership in the next generation of power batteries [50][49]. 4. U.S. Market Dynamics - The U.S. solid-state battery sector is characterized by a focus on startup companies and significant capital investment, with policies aimed at reducing reliance on foreign supply chains and fostering domestic innovation [62][68]. - Major players like QuantumScape and Solid Power are leading the charge in technology validation and partnerships with automotive manufacturers [69][78]. 5. Japan and South Korea’s Strategies - Japan is leveraging its material innovation capabilities to regain leadership in the battery sector, with a focus on solid-state technology as a critical component of its national strategy [83]. - South Korea is enhancing its production capabilities through collaboration among major companies like Samsung SDI and LGES, aiming for accelerated commercialization of solid-state batteries [83].

配股引入战略投资者，AI First 持续推进 浪潮数字企业跟踪报告 本报告导读： 公司配股落地，引入战略投资者并加大在人工智能等技术领域的研发投入，夯实 AI 优先战略，看好公司价值回归。 投资要点： 证 券 研 究 报 告 请务必阅读正文之后的免责条款部分 股 票 研 究 | 财务摘要(百万人民币) | 2023 | 2024 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 8,294 | 8,201 | 8,962 | 9,863 | 11,001 | | (+/-)% | 19.1% | -1.1% | 9.3% | 10.1% | 11.5% | | 毛利润 | 1,918 | 2,208 | 2,509 | 2,860 | 3,300 | | 净利润 | 202 | 385 | 553 | 703 | 892 | | (+/-)% | 69.9% | 90.8% | 43.7% | 27.1% | 26.9% | | PE | 38.13 | 19.99 | 14.04 | 11.05 | 8.71 ...

Investment Rating - The report does not explicitly provide an investment rating for the industry or specific companies [1]. Core Insights - The second round of IRA negotiation prices will be effective in 2027, with 15 drugs added, 11 of which will see price reductions of at least 50%, and the highest reduction reaching 85% [4]. - The average price reduction across the drugs is 52%, effective January 1, 2027 [4]. - Small molecule drugs are exempt from price negotiations for 9 years post-approval, while biologics are exempt for 13 years [4]. - The largest price cut is for the diabetes drug Janumet/Janumet XR, reducing from $526/month to $80/month, an 85% reduction [4]. - The smallest cut is for the rare disease drug Austedo/Austedo XR, reducing from $6623/month to $4039/month, a 38% reduction [4]. - Semaglutide's three trade names will see a reduction from $959/month to $274/month, a 71% reduction [4]. - Acalabrutinib will reduce from $14228/month to $8600/month, a 40% reduction [4]. - Medicare Part D spending could save 44%, approximately $12 billion, with an estimated 5.3 million beneficiaries using these drugs [4]. - The impact of IRA negotiations is expected to be limited due to the imminent patent cliffs, as many small molecules will have been on the market for over 9 years by the time prices are implemented [4]. Summary by Sections Price Negotiation Results - The second round of Medicare negotiations added 15 drugs, with significant price reductions [4]. - The average price reduction is 52%, with the highest reduction being 85% for Janumet/Janumet XR [4]. Drug-Specific Price Changes - Janumet/Janumet XR: from $526 to $80/month (85% reduction) [4]. - Austedo/Austedo XR: from $6623 to $4039/month (38% reduction) [4]. - Semaglutide: from $959 to $274/month (71% reduction) [4]. - Acalabrutinib: from $14228 to $8600/month (40% reduction) [4]. Financial Implications - Estimated savings for Medicare Part D could reach $12 billion, accounting for 44% of costs [4]. - Approximately 5.3 million beneficiaries will be affected, representing 15% of total prescription drug coverage costs [4]. Market Context - The report highlights the limited impact of IRA negotiations due to the approaching patent cliffs for many drugs [4]. - Global pharmaceutical companies may increase acquisitions in response to the challenges posed by patent expirations [4].

Investment Rating - The report maintains an "Outperform" rating for Super Hi International Holding [2][15]. Core Views - The company has shown improvement in table turnover rates and is steadily advancing its multi-brand strategy. The revenue for 3Q25 reached USD 210 million, a year-on-year increase of 7.8%, while net profit attributable to shareholders decreased by 90.4% to USD 3.609 million due to increased foreign exchange losses [3][4][15]. Financial Performance Summary - Revenue projections for 2025-2027 are maintained at USD 856 million, USD 952 million, and USD 1.064 billion, reflecting year-on-year growth rates of 10.0%, 11.2%, and 11.7% respectively [8][15]. - Net profit attributable to shareholders is forecasted to be USD 40 million in 2025, USD 50 million in 2026, and USD 70 million in 2027, with corresponding growth rates of 102.4%, 23.5%, and 25.6% [8][15]. - The gross profit margin is projected to be around 66.3% in 2025, with net profit margins of 5.2%, 5.7%, and 6.4% for 2025, 2026, and 2027 respectively [8][15]. Operational Insights - The company’s restaurant operations generated USD 200 million in revenue for 3Q25, a 5.1% increase year-on-year, driven by network expansion and enhanced brand influence [4][5]. - The takeaway business saw significant growth, with revenue increasing by 69.2% to USD 4.4 million, attributed to product optimization and strategic marketing collaborations [4][5]. - The average table turnover rate improved to 3.9 times per day, reflecting the effectiveness of the company's customer and employee incentive strategies [5][6]. Market Position and Valuation - The target price is set at HKD 18.4, corresponding to a market capitalization of HKD 11.98 billion, based on a price-to-sales (P/S) ratio of 1.8 [2][15]. - The company’s current market capitalization is approximately HKD 9.25 billion, with a share price of HKD 14.22 as of November 27, 2025 [2][15].

Investment Rating - The report maintains a NEUTRAL rating for Li Auto with a target price of HK$81.34, reflecting a current price of HK$71.70 [2][6]. Core Insights - The one-off recall has disrupted quarterly earnings, but there is potential for a rapid recovery in Q4. The company reported a revenue of RMB 27.4 billion for Q3 2025, down 36% year-on-year and 10% quarter-on-quarter, with vehicle sales contributing RMB 25.9 billion [3][10]. - Li Auto is focusing on the 2026 facelifted L series as a growth driver, aiming to reclaim its leadership in the extended-range electric vehicle (EREV) segment. The company has started deliveries of the i6/i8 battery electric vehicle (BEV) models, enhancing its market presence [4][11]. - An organizational restructuring has been implemented to enhance decision-making speed and operational resilience, shifting back to a startup-style management approach [5][12]. Financial Summary - Revenue projections for 2025, 2026, and 2027 have been adjusted to RMB 111.6 billion, RMB 122.0 billion, and RMB 136.8 billion, respectively, reflecting a decrease of 14%, 28%, and 33% [6][13]. - The report indicates a non-GAAP net loss of RMB 360 million for Q3 2025, but underlying profitability is expected to return in Q4 2025 [3][10]. - The gross margin for Q3 was reported at 16.3%, with an underlying margin of 20.4% when excluding the recall impact [3][10].

Investment Rating - The report maintains an "Outperform" rating for the company [4][9]. Core Views - The company is projected to achieve revenues of 28.65 billion RMB, 29.41 billion RMB, and 30.69 billion RMB for the years 2025 to 2027, with net profits attributable to shareholders of 951 million RMB, 1.02 billion RMB, and 1.11 billion RMB respectively [4][9]. - The earnings per share (EPS) are expected to be 0.74 RMB, 0.79 RMB, and 0.86 RMB for the same period [4][9]. - The target price is set at 27.76 RMB based on a 2026 price-to-earnings (PE) ratio of 35x [4][9]. Financial Summary - For the first three quarters of 2025, the company reported revenues of 17.07 billion RMB, a year-on-year decrease of 19.3%, while net profit attributable to shareholders was 513 million RMB, reflecting a year-on-year increase of 30.28% [4][9]. - The gross profit margin (GPM) for the first three quarters of 2025 was 22.42%, an increase of 0.29 percentage points year-on-year [4][9]. - In Q3 2025, the company achieved revenues of 5.96 billion RMB, down 18.48% year-on-year and 15.75% quarter-on-quarter, with a net profit of 226 million RMB, up 28.14% year-on-year [4][9]. Market Position and Strategy - The domestic market is focused on consolidating existing market share while accelerating the layout of new products, with successful bids for centralized procurement projects in optical networks [10]. - The international market is showing improvement, with significant market share gains in Southeast Asia, the Americas, and Africa for optical network and broadband products [10]. - The company is deepening its presence in the information market, securing major projects and integrating its core capabilities in cloud, data, and computing to form a unique competitive solution [10].

Investment Rating - The report maintains a positive outlook on the thermal power sector, indicating an investment rating of "Outperform" for the industry [1][21]. Core Insights - The report highlights that restrictions on power company profits are stabilizing electricity prices. In October, total electricity consumption reached 857.2 billion kWh, reflecting a year-on-year increase of 10.4%. This growth is attributed to low base effects from the previous year, with industrial, commercial, and residential usage increasing by 6.2%, 17.1%, and 23.9% respectively [3][4]. - The report anticipates that annual electricity consumption growth will exceed 5%, with concerns regarding long-term contract prices and coal prices expected to ease after agreements are finalized [3][4]. Summary by Sections Regional Policies - Various regions are implementing profit-sharing policies for power companies. For instance, Henan limits user losses to 10%, while Guangdong shares excess profits above RMB 0.01/kWh at a 1:9 ratio. Other regions like Shaanxi, Anhui, Jiangxi, and Sichuan have also introduced price caps, with Guangdong's sharing ratio being notably favorable to users [5][6]. Market Forecasts - The China Energy Investment Corporation forecasts that the peak load for 2024 will be 1.44 billion kW, with coal power expected to provide 55% of the energy. By 2030, coal capacity is projected to reach 1.54 billion kW, with gas power adding 40-50 million kW [7][8]. Profitability and Recommendations - The report notes that profits in Q3 2025 for thermal power companies are improving, with a price-to-earnings (PE) ratio below 10. It suggests that dividends are likely to rise, and compares this favorably to global leaders in the sector, which typically have a PE around 20. Recommended companies include Huadian Power International, Beijing Jingneng Power, and others [8].